Key Highlights
- GE HealthCare introduces Prostate Volume Assist, a cutting-edge AI software feature, aimed at optimizing prostate imaging and biopsies.
- The AI tool simplifies prostate volume measurement with an automated, one-click process, enhancing treatment planning and decision-making.
- Available on the bkActiv, bk3000/5000, and bkSpecto systems, PVA is set to debut at major urology congresses, showcasing its global availability and support.
Source: Business Wire
Notable Quote
- “This technology provides urologists with a unique solution to enhance workflows, guide surgical urology procedures, and allow them to quickly retrieve the important details they need to make critical treatment decisions.” – Urvi Vyas, General Manager, Surgical Visualization and Guidance, Ultrasound at GE HealthCare
SoHC's Take
GE HealthCare’s Prostate Volume Assist (PVA) represents a significant leap in the field of urology, offering an AI-driven approach to improve the efficiency and accuracy of prostate imaging and biopsies. This tool not only streamlines the measurement process but also supports clinicians in making more informed treatment decisions, particularly crucial in managing prostate cancer, a leading cause of cancer-related deaths among men. The launch of PVA underscores GE HealthCare’s commitment to advancing medical technology and supporting healthcare professionals with innovative solutions. The global availability of PVA, showcased at major urology events, reinforces GE HealthCare’s role as a trusted partner in surgical visualization and guidance, promising to enhance patient care through precision and efficiency.
